Development of Reliable Aqueous Solubility Models and Their Application in Druglike Analysis (original) (raw)

The influence of drug-like concepts on decision-making in medicinal chemistry

Paul D Leeson

Nature Reviews Drug Discovery, 2007

View PDFchevron_right

Experimental and computational screening models for prediction of aqueous drug solubility

Per Artursson

Pharmaceutical Research, 2002

View PDFchevron_right

Discriminating between Drugs and Nondrugs by Prediction of Activity Spectra for Substances (PASS

Vladimir Poroikov

Journal of Medicinal Chemistry, 2001

View PDFchevron_right

Assessment of chemical libraries for their druggability

George Hatzakis

Computational Biology and Chemistry, 2005

View PDFchevron_right

In Silico Tools for Drug Absorption Prediction

George Grass

American Journal of Drug Delivery, 2003

View PDFchevron_right

Prediction of Partition Coefficients and Permeability of Drug Molecules in Biological Systems with Abraham Model Solute Descriptors Derived from Measured Solubilities and Water-to-Organic Solvent Partition Coefficients

Michael Abraham

Toxicity and Drug Testing, 2012

View PDFchevron_right

Biopharmaceutic Classification System: A Scientific Framework for Pharmacokinetic Optimization in Drug Research

Amit Jain

Current Drug Metabolism, 2004

View PDFchevron_right

In Silico Approaches to Prediction of Aqueous and DMSO Solubility of Drug-Like Compounds: Trends, Problems and Solutions

Igor Tetko

Current Medicinal Chemistry, 2006

View PDFchevron_right

Quantitative Structure–Property Relationship Modeling: A Valuable Support in High-Throughput Screening Quality Control

Igor Baskin

Analytical Chemistry, 2014

View PDFchevron_right

Combined in silico and in vitro Approach to Drug Screening

donatella verbanac

View PDFchevron_right

Post-High-Throughput Screening Analysis: An Empirical Compound Prioritization Scheme

Eric Prossnitz

Journal of Biomolecular Screening, 2005

View PDFchevron_right

pH-Dependent Solubility and Permeability Criteria for Provisional Biopharmaceutics Classification (BCS and BDDCS) in Early Drug Discovery

Ayman El-kattan

Molecular Pharmaceutics, 2012

View PDFchevron_right

Pharmacophore modeling: advances, limitations, and current utility in drug discovery

Joren Raeymaecker, Marc De Maeyer

Journal of Receptor, Ligand and Channel Research, 2014

View PDFchevron_right

Experimental and Computational Screening Models for the Prediction of Intestinal Drug Absorption

Per Artursson

Journal of Medicinal Chemistry, 2001

View PDFchevron_right

Straightforward Recursive Partitioning Model for Discarding Insoluble Compounds in the Drug Discovery Process

Alessandro Padova

Journal of Medicinal Chemistry, 2008

View PDFchevron_right

Use of Catalyst Pharmacophore Models for Screening of Large Combinatorial Libraries

Chaya Duraiswami

Journal of Chemical Information and Computer Sciences, 2002

View PDFchevron_right

Towards Understanding Drugs on the Molecular Level to Design Drugs of Desired Profiles

Jolanta N Latosińska

View PDFchevron_right

Structural models in the assessment of protein druggability based on HTS data

Anvita Gupta

Journal of Computer-aided Molecular Design, 2009

View PDFchevron_right

Integrated oral bioavailability projection using in vitro screening data as a selection tool in drug discovery

Joanne Brodfuehrer

International Journal of Pharmaceutics, 2004

View PDFchevron_right

Improving the Odds in Discriminating "Drug-like" from "Non Drug-like" Compounds

Robert Bywater

Journal of Chemical Information and Modeling, 2000

View PDFchevron_right

Critical Evaluation of Human Oral Bioavailability for Pharmaceutical Drugs by Using Various Cheminformatics Approaches

Suman Chakravarti

Pharmaceutical Research, 2014

View PDFchevron_right

Biopharmaceutics classification systems for new molecular entities (BCS-NMEs) and marketed drugs (BCS-MD): Theoretical basis and practical examples

Vasiliki Papadopoulou, Georgia Valsami

International Journal of Pharmaceutics, 2008

View PDFchevron_right

Modelling approaches for rational solvent selection in drug development : enhancing the solubility prediction of small molecules

Bruce Wareham

University of Strathclyde, 2019

View PDFchevron_right

A fresh look at pharmaceutical screening library design

Ramaswamy Nilakantan

Drug Discovery Today, 2003

View PDFchevron_right

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Christopher Lipinski

Advanced Drug Delivery Reviews, 1997

View PDFchevron_right

High-throughput structure-based pharmacophore modelling as a basis for successful parallel virtual screening

Christian Laggner, Daniela Schuster

Journal of Computer-Aided Molecular Design, 2007

View PDFchevron_right

Calculation of drug-like molecules solubility using predictive activity coefficient models

Alfonsina Andreatta, Fátima Mota

Fluid Phase Equilibria, 2012

View PDFchevron_right

Avoiding investment in doomed drugs, is poor solubility an industry wide problem

Christopher Lipinski

View PDFchevron_right

Integrating computer-based de novo drug design and multidimensional filtering for desirable drugs

Carl Elkin, Jeanpierre Wery

TARGETS, 2002

View PDFchevron_right